Delivery Order SPE2DX22D0010-SPE2D826FAN48
Award Date 10/22/25
Potential Completion Date 10/23/25
Potential Value $23K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Vyvanse (lisdexamfetamine) 30mg capsules under a firm fixed-price contract with a ceiling value of $30,816.60. This delivery order, awarded on September 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical. The award was competitively awarded with no set-aside designation...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,459 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 30mg, a controlled substance primarily used to treat attention-deficit/hyperactivity disorder. This competitively awarded, firm fixed-price contract was executed on September 15, 2025, with an ultimate completion date of September 16, 2025, and carries no set-aside designation. The work will be performed at the vendor's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on October 6, 2025, for the supply of Vyvanse capsules (20 mg) valued at $3,108.21. This firm fixed-price contract, which is set to be completed by October 7, 2025, supports the Medical Supply Chain division of the Defense Logistics Agency. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Vyvanse 20mg tablets (100 count) valued at $32,104.80. This firm fixed price delivery order, with an ultimate completion date of September 5, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The product will be delivered to...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,658.76 to AmerisourceBergen Drug Corp for the supply of Vyvanse capsules (30 mg) on August 20, 2025. This firm fixed-price delivery order, which is expected to be completed by August 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively procured with no set-aside designation, leveraging...
- The Defense Logistics Agency awarded a delivery order valued at $1,831.88 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 20 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder. The award, issued on July 8, 2025, with an ultimate completion date of July 9, 2025, represents a firm fixed-price delivery order with no set-aside designation. This order was fulfilled from AmerisourceBergen's place of performance in Conshohocken,...
- The Defense Logistics Agency awarded a $3,163.85 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 50 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder. The contract, awarded on July 24, 2025, with completion targeted for July 25, 2025, carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled from AmerisourceBergen's location in...
- The Defense Logistics Agency Medical Supply Chain awarded a $3,792.99 delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Vyvanse capsules (10mg), a medication commonly used in the treatment of attention deficit hyperactivity disorder and binge eating disorder. This is a firm fixed price delivery order with an ultimate completion date of October 15, 2025, and carries no set-aside designation, indicating it was competitively awarded. The contract will be performed...
- The U.S. Department of Defense's Medical Supply Chain awarded a $54.8K delivery order to AmerisourceBergen Drug Corp for supply of Vyvanse capsules (30mg) under a firm fixed-price contract. The delivery order, issued on September 11, 2025, with completion targeted for September 12, 2025, was competitively awarded with no set-aside designation. Performance will occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company maintains substantial pharmaceutical...
- The Defense Logistics Agency awarded a $2,090.85 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 30 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder (ADHD). This competitively awarded, firm fixed-price delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025, and represents a direct fulfillment of pharmaceutical supply needs through the federal medical procurement system. The...